Back to search

Total Citations Per Year

Abstract

References (22)

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

2009 • 10,717 citations

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

2007 • 4,623 citations

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

2006 • 2,724 citations

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

2009 • 2,144 citations

Pharmacology and Management of the Vitamin K Antagonists

2008 • 2,084 citations

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

2006 • 1,924 citations

Atrial fibrillation management: a prospective survey in ESC Member Countries

2005 • 828 citations

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

2010 • 773 citations

Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation

2003 • 717 citations

Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement

2009 • 686 citations

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

2010 • 442 citations

Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States

2009 • 416 citations

Avoiding Central Nervous System Bleeding During Antithrombotic Therapy

2005 • 361 citations

Persistent Use of Secondary Preventive Drugs Declines Rapidly During the First 2 Years After Stroke

2010 • 318 citations

Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation

2006 • 302 citations

New Anticoagulants

2010 • 239 citations

Management of atrial fibrillation

2007 • 209 citations

Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation

2010 • 189 citations

Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment

2010 • 164 citations

Alternative endpoints for mortality in studies of patients with atrial fibrillation: The AFFIRM study experience

2004 • 49 citations

The management of atrial fibrillation

2001 • 28 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
Apixaban in Patients with Atrial Fibrillation (2011) – New England Journal of Medicine | Metascience Observatory Explorer